185 related articles for article (PubMed ID: 19424586)
61. In vitro combination effect of 5-fluorouracil and cisplatin on the proliferation, morphology and expression of Ki-67 antigen in human gastric cancer cells.
Imada T; Rino Y; Takahashi M; Amano T; Kusada O; Kitaura K
Anticancer Drugs; 1997 Nov; 8(10):1000-6. PubMed ID: 9436643
[TBL] [Abstract][Full Text] [Related]
62. Curcumin and paclitaxel induce cell death in breast cancer cell lines.
Calaf GM; Ponce-Cusi R; Carrión F
Oncol Rep; 2018 Oct; 40(4):2381-2388. PubMed ID: 30066930
[TBL] [Abstract][Full Text] [Related]
63. The synergistic cytotoxicity of cisplatin and taxol in killing oral squamous cell carcinoma.
Huang GC; Liu SY; Lin MH; Kuo YY; Liu YC
Jpn J Clin Oncol; 2004 Sep; 34(9):499-504. PubMed ID: 15466821
[TBL] [Abstract][Full Text] [Related]
64. Sageone, a diterpene from Rosmarinus officinalis, synergizes with cisplatin cytotoxicity in SNU-1 human gastric cancer cells.
Shrestha S; Song YW; Kim H; Lee DS; Cho SK
Phytomedicine; 2016 Dec; 23(13):1671-1679. PubMed ID: 27823632
[TBL] [Abstract][Full Text] [Related]
65. Enhancement of Cisplatin Cytotoxicity by Cu(II)-Mn(II) Schiff Base Tetradentate Complex in Human Oral Squamous Cell Carcinoma.
Al-Serwi RH; Othman G; Attia MA; Enan ET; El-Sherbiny M; Mahmoud S; Elsherbiny N
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066414
[TBL] [Abstract][Full Text] [Related]
66. Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin α2/β5/FAK signaling pathway.
Liu F; Tong D; Li H; Liu M; Li J; Wang Z; Cheng X
Oncotarget; 2016 Feb; 7(8):8896-907. PubMed ID: 26758421
[TBL] [Abstract][Full Text] [Related]
67. An effective in vitro antitumor response against human pancreatic carcinoma with paclitaxel and daunorubicin by induction of both necrosis and apoptosis.
Gervasoni JE; Hindenburg AA; Vezeridis MP; Schulze S; Wanebo HJ; Mehta S
Anticancer Res; 2004; 24(5A):2617-26. PubMed ID: 15517865
[TBL] [Abstract][Full Text] [Related]
68. Fucoidan upregulates TLR4/CHOP-mediated caspase-3 and PARP activation to enhance cisplatin-induced cytotoxicity in human lung cancer cells.
Hsu HY; Lin TY; Hu CH; Shu DTF; Lu MK
Cancer Lett; 2018 Sep; 432():112-120. PubMed ID: 29746926
[TBL] [Abstract][Full Text] [Related]
69. Involvement of microtubules and mitochondria in the antagonism of arsenic trioxide on paclitaxel-induced apoptosis.
Carré M; Carles G; André N; Douillard S; Ciccolini J; Briand C; Braguer D
Biochem Pharmacol; 2002 May; 63(10):1831-42. PubMed ID: 12034367
[TBL] [Abstract][Full Text] [Related]
70. Synergistic enhancement of the antitumor activity of 5-fluorouracil by bornyl acetate in SGC-7901 human gastric cancer cells and the determination of the underlying mechanism of action.
Li J; Wang SX
J BUON; 2016; 21(1):108-17. PubMed ID: 27061538
[TBL] [Abstract][Full Text] [Related]
71. Combination of SNX-2112 with 5-FU exhibits antagonistic effect in esophageal cancer cells.
Liu Y; Wang X; Wang Y; Zhang Y; Zheng K; Yan H; Zhang L; Chen W; Wang X; Liu Q; Wang S; Wang Y
Int J Oncol; 2015 Jan; 46(1):299-307. PubMed ID: 25333998
[TBL] [Abstract][Full Text] [Related]
72. Synergistic antitumor activity of pro-apoptotic agent PAC-1 with cisplatinum by the activation of CASP3 in pulmonary adenocarcinoma cell line H1299.
Huang JQ; Liang HL; Zhang XC; Xie Z; Jin TE
Asia Pac J Clin Oncol; 2016 Mar; 12(1):41-51. PubMed ID: 26620316
[TBL] [Abstract][Full Text] [Related]
73. Wogonin potentiates cisplatin-induced cancer cell apoptosis through accumulation of intracellular reactive oxygen species.
He F; Wang Q; Zheng XL; Yan JQ; Yang L; Sun H; Hu LN; Lin Y; Wang X
Oncol Rep; 2012 Aug; 28(2):601-5. PubMed ID: 22665077
[TBL] [Abstract][Full Text] [Related]
74. Evaluation of GL331 in combination with paclitaxel: GL331's interference with paclitaxel-induced cell cycle perturbation and apoptosis.
Huang TS; Shu CH; Chao Y; Chen LT
Anticancer Drugs; 2001 Mar; 12(3):259-66. PubMed ID: 11290873
[TBL] [Abstract][Full Text] [Related]
75. The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas.
Tian XP; Qian D; He LR; Huang H; Mai SJ; Li CP; Huang XX; Cai MY; Liao YJ; Kung HF; Zeng YX; Xie D
Cancer Lett; 2014 Oct; 353(1):104-14. PubMed ID: 25045845
[TBL] [Abstract][Full Text] [Related]
76. Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs.
Duarte D; Cardoso A; Vale N
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299028
[TBL] [Abstract][Full Text] [Related]
77. The mechanism and inhibitory effect of recombinant human P53 adenovirus injection combined with paclitaxel on human cervical cancer cell HeLa.
Liu YG; Zheng XL; Liu FM
Eur Rev Med Pharmacol Sci; 2015; 19(6):1037-42. PubMed ID: 25855930
[TBL] [Abstract][Full Text] [Related]
78. Cisplatin cytotoxicity is increased by mifepristone in cervical carcinoma: an in vitro and in vivo study.
Jurado R; Lopez-Flores A; Alvarez A; García-López P
Oncol Rep; 2009 Nov; 22(5):1237-45. PubMed ID: 19787245
[TBL] [Abstract][Full Text] [Related]
79. Schedule-dependent antagonism of paclitaxel and cisplatin in human gastric and ovarian carcinoma cell lines in vitro.
Vanhoefer U; Harstrick A; Wilke H; Schleucher N; Walles H; Schröder J; Seeber S
Eur J Cancer; 1995; 31A(1):92-7. PubMed ID: 7695986
[TBL] [Abstract][Full Text] [Related]
80. Anti-tumor mechanism of IL-21 used alone and in combination with 5-fluorouracil in vitro on human gastric cancer cells.
Fu ZQ; Zhou Q; Zhu S; Liu W
J Biol Regul Homeost Agents; 2018; 32(3):619-625. PubMed ID: 29921390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
